Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Slingluff, CL; Fling, S; Mauldin, IS; Ernstoff, MS; Hanks, BA; Delman, KA; Lawson, DH; Gastman, B; Kaiser, JC; Cheever, MA

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 3033 - 3033

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.3033